Cagrilintide 10mg Peptides
Serious research starts with materials that meet exacting, dependable standards.
Better Molecule Cagrilintide is provided as a peptide lyophilized vial, purpose-built for controlled laboratory workflows. This neutral, dry-powder format supports careful method development and reproducibility, while the single-vial presentation simplifies inventory control and chain-of-custody. Each unit delivers a total of 10mg of cagrilintide peptide, prepared for qualified research teams that require consistent handling, reliable characterization, and clear documentation.
- Each vial contains 10mg of Cagrilintide, a well-characterized amylin analogue investigated in metabolic pathway research, presented as a lyophilized powder to support stability, accurate aliquoting, and precise experimental design.
In use, the lyophilized format is designed to support clean, controlled reconstitution under appropriate laboratory conditions, enabling accurate measurement, consistent sample preparation, and repeatable bench performance. The presentation is suited to protocol development, assay optimization, and other non-clinical applications where material integrity, lot traceability, and consistent composition are essential to sound data.
Quality, transparency, and control guide every lot. Better Molecule sources and handles peptides with a focus on purity and consistency, supported by analytical verification such as HPLC for composition and appropriate identity confirmation methods. Each lot is released against defined specifications and supported by documentation to aid method validation and internal QA review. Vials are prepared in a controlled environment and finished with meticulous labeling for clear lot identification.
Trusted research standards are the foundation of the brand. As a USA-based supplier, Better Molecule emphasizes rigorous quality systems, careful handling, and responsible distribution. Certificates of analysis are available for lot review, and every product is presented with the professionalism expected in modern laboratories. For investigators who require reliable materials and straightforward documentation, this cagrilintide vial reflects the same disciplined approach applied across our peptide portfolio.
For laboratory research use only. Not for human consumption, clinical use, therapeutic use, or veterinary use. Use only by qualified professionals in appropriate research settings and according to institutional and regulatory requirements.
- Most orders ship within 24 hours and arrive within 3 to 5 days of leaving our warehouse.
- Shipping is free on orders of $99+ (except Hawaii and Alaska).
- All orders ship in discreet packaging via USPS Ground Advantage mail.
Delivery restrictions vary by state.
This Product Contains
Customer Reviews
There are no reviews yet. Be the first to write a review!
Frequently Asked Questions
What is Cagrilintide?
Cagrilintide is a long-acting amylin analog used in metabolic research. It belongs to the incretin-adjacent appetite-regulation space rather than the classic growth-hormone or repair-peptide category. On a product page, the accurate framing is that it is a research compound studied for metabolic signaling, not an approved consumer-use peptide.
What is Cagrilintide typically studied for?
Cagrilintide is usually studied in relation to appetite regulation, satiety signaling, gastric-emptying effects, and body-weight change in experimental models. It is also often discussed alongside GLP-1-based research because both areas intersect around energy intake and metabolic control.
What are GH peptides?
GH peptides — short for growth-hormone-related peptides — are a research category that includes two main subgroups. The first is growth-hormone-releasing hormone (GHRH) analogs, such as Sermorelin, Tesamorelin, and CJC-1295, which are studied for their interaction with the GHRH receptor. The second is growth hormone secretagogues, such as Ipamorelin, GHRP-2, GHRP-6, and Hexarelin, which are studied for their interaction with the ghrelin receptor (GHS-R1a).
Both subgroups are investigated in the research context of growth-hormone-axis biology. All GH peptide products from Better Molecule are lyophilized research compounds intended solely for in vitro laboratory investigation.
How do GH peptides differ from recombinant growth hormone?
Recombinant human growth hormone is the full 191-amino-acid human GH protein, produced via recombinant DNA technology. It is essentially identical to the endogenous hormone itself. GH peptides, by contrast, are much shorter sequences — typically on the order of a few to a few dozen amino acids — that do not act as GH themselves but rather engage upstream receptors (GHRH-R or GHS-R1a) involved in the GH signaling axis.
This makes the two categories mechanistically distinct. Recombinant GH is a replacement of the hormone itself, while GH peptides are research tools for studying the regulatory machinery that controls endogenous GH release.
What is the difference between GHRH analogs and GH secretagogues?
GHRH analogs are peptides modeled on the natural growth-hormone-releasing hormone sequence. They are studied for their ability to bind the GHRH receptor on the pituitary — the same receptor used by endogenous GHRH. Examples include Sermorelin (a GHRH 1-29 analog), Tesamorelin, and CJC-1295.
GH secretagogues are a structurally different class of peptides that act through the growth hormone secretagogue receptor (GHS-R1a), better known as the ghrelin receptor. Examples include Ipamorelin, GHRP-2, GHRP-6, and Hexarelin. The two classes engage different receptors and are therefore studied as distinct pharmacological families in research on GH signaling.
